Filing Details

Accession Number:
0001567619-21-020114
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-12 19:00:05
Reporting Period:
2021-11-10
Accepted Time:
2021-11-12 19:00:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1630627 Treace Medical Concepts Inc. TMCI Surgical & Medical Instruments & Apparatus (3841) 471052611
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1856371 F. Sean Scanlan C/O Treace Medical Concepts, Inc.
203 Fort Wade Road, Suite 150
Ponte Vedra FL 32081
Svp, Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-10 25,000 $1.57 25,000 No 4 M Direct
Common Stock Disposition 2021-11-10 24,560 $21.53 440 No 4 S Direct
Common Stock Disposition 2021-11-10 440 $22.20 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2021-11-10 25,000 $0.00 25,000 $1.57
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
57,524 2029-04-23 No 4 M Direct
Footnotes
  1. Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
  2. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $21.14 to $22.13 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $22.15 to $22.26 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The stock option is partially vested and will vest with respect to the remaining shares in equal annual installments, so that the options will be fully vested on April 23, 2023.